US 11,942,202 B2
Burden-free blood glucose management for insulin-requiring diabetes with minimal user interaction
Lane Desborough, Thousand Oaks, CA (US)
Assigned to Nudge BG, Inc., Thousand Oaks, CA (US)
Filed by Nudge BG, Inc., Thousand Oaks, CA (US)
Filed on Aug. 16, 2021, as Appl. No. 17/403,518.
Application 17/403,518 is a continuation of application No. 17/149,598, filed on Jan. 14, 2021, granted, now 11,101,030.
Claims priority of provisional application 62/962,178, filed on Jan. 16, 2020.
Claims priority of provisional application 62/962,179, filed on Jan. 16, 2020.
Prior Publication US 2021/0375422 A1, Dec. 2, 2021
Int. Cl. G16H 20/17 (2018.01); A61M 5/142 (2006.01); A61M 5/172 (2006.01); G05B 23/02 (2006.01); G16H 40/40 (2018.01); G16H 40/67 (2018.01)
CPC G16H 20/17 (2018.01) [A61M 5/14248 (2013.01); A61M 5/1723 (2013.01); G05B 23/0272 (2013.01); G16H 40/40 (2018.01); G16H 40/67 (2018.01); A61M 2205/18 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/502 (2013.01); A61M 2230/201 (2013.01)] 21 Claims
OG exemplary drawing
 
1. A method comprising:
receiving previous insulin delivery data at a user device from an insulin pump;
receiving at the user device estimated glucose data from a continuous glucose monitor;
determining an insulin delivery amount based on the previous insulin delivery data and the estimated glucose data;
communicating instructions to an insulin pump to deliver the insulin delivery amount; and
not providing data representative of the estimated glucose data or the insulin delivery data to a user through a user interface of the user device.